The level of OGD-induced ferroptosis in ADSCs was assessed according to the viability of cells treated with the ferroptosis inhibitor Ferrostatin-1 (Fer-1) 5 M, autophagy inhibitor 3-Methyladenine (3-MA) 5 mM, apoptosis inhibitor Z-VAD-FMK 10 M, necroptosis inhibitor Necrostatin-1 (Nec-1) 50 M, or ferroptosis activator erastin
GHK-Cu dosage should always be calibrated to your specific goal, body weight, and tolerance
Anything that upregulates growth pathways warrants long-term safety evaluation
Patients often report improved recovery times, decreased soreness, and better exercise tolerance
In total, 124 women received 500 mg l-cystine plus 250 mg glutathione daily for 12 weeks
Please refer to them for full details.